ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ICAD Icade

27.98
0.78 (2.87%)
Last Updated: 15:21:31
Delayed by 15 minutes
Share Name Share Symbol Market Type
Icade EU:ICAD Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.78 2.87% 27.98 27.94 28.00 28.16 27.10 27.24 111,552 15:21:31

iCAD to Present at AeA Classic

01/11/2005 5:01pm

PR Newswire (US)


Icade (EU:ICAD)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Icade Charts.
NASHUA, N.H., Nov. 1 /PRNewswire-FirstCall/ -- iCAD(R), Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions, today announced that W. Scott Parr, President and CEO of iCAD, Inc., will be presenting at the AeA Classic Financial Conference on November 8 and 9, 2005 at the Manchester Grand Hyatt in San Diego, California. iCAD Presentation Dates and Time: * Tuesday, November 8, 2005 - Hourly from 1:00 p.m. to 4:00 p.m. (Pacific Time) * Wednesday, November 9, 2005 - Hourly from 9:00 a.m. to 12:00 p.m. (Pacific Time) Over 200 presenting companies and 800 investors are expected to participate in the AeA Classic Conference hosted by AeA, the nation's largest high-tech trade association. Additional conference information can be found at http://www.aeanet.org/. About iCAD, Inc. iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to identify cancer and other life-threatening conditions earlier by making medical services more effective, more accessible and more affordable for patients worldwide. Recipient of Frost & Sullivan's Growth Strategy Leadership award, iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over eleven hundred women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com/. iCAD and Second Look are registered trademarks of iCAD, Inc. For iCAD investor relations, contact Kevin McGrath of Cameron Associates at +1 212 245 4577 or via email at . For all other iCAD inquires, contact Monica Pandolfi of SHIFT Communications at +1 617 681 1235 or via email at . DATASOURCE: iCAD, Inc. CONTACT: Kevin McGrath, investor relations, of Cameron Associates for iCAD, +1-212-245-4577, ; or Monica Pandolfi of SHIFT Communications, +1-617-681-1235, Web site: http://www.icadmed.com/ http://www.aeanet.org/

Copyright

1 Year Icade Chart

1 Year Icade Chart

1 Month Icade Chart

1 Month Icade Chart

Your Recent History

Delayed Upgrade Clock